Chuan-Yuan Li

11PUBLICATIONS
19CO-AUTHORS
Molecular targetsIndustrial molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 11, 2026
DGAT1 Inhibition Induces Ferroptosis and Enhances Cancer Immunotherapy Efficacy.

Dong Pan, Meng Jiao, Yanyan Zhu

|Aug 08, 2025
A noncanonical cytoplasmic role for BUB1 in restraining DNA damage-induced dsRNA accumulation and sensing within stress granules.

Mengjie Hu, Dong Pan, Meng Jiao

|Aug 01, 2024
Targeting Catechol-O-Methyltransferase Induces Mitochondrial Dysfunction and Enhances the Efficacy of Radiotherapy in Glioma.

Meng Jiao, Christopher J Pirozzi, Chen Yu

|Jul 08, 2024
Caspase-3 promotes oncogene-induced malignant transformation via EndoG-dependent Src-STAT3 phosphorylation.

Chenchen Zhu, Fushun Fan, Chuan-Yuan Li

|Dec 11, 2023
VHL loss enables immune checkpoint blockade therapy by boosting type I interferon response.

Meng Jiao, Xuhui Bao, Mengjie Hu

|Jun 01, 2022
SETDB1 Restrains Endogenous Retrovirus Expression and Antitumor Immunity during Radiotherapy.

Dong Pan, Xuhui Bao, Mengjie Hu

Pageof 2

Frequent Collaborators

5 joint publications

Meng Jiao

3 joint publications

Fang Li

3 joint publications

Dong Pan

3 joint publications

Mengjie Hu